The Veterinary Pharmaceuticals Market is expected to register a CAGR of 9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Veterinary Pharmaceuticals Market report covers segmental analysis by Product (Vaccines, Antibiotics, Parasiticides, Others); End User (Hospitals, Clinics, Pharmacies And Drug Stores); Route of Administration (Oral, Others); Type of Animals (Livestock, Companion Animals); Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others); Antibiotics (Tetracyclines, Penicillins, Sulphonamides, Macrolides, Aminoglycosides, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Veterinary Pharmaceuticals Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Veterinary Pharmaceuticals Market Segmentation
Product- Vaccines
- Antibiotics
- Parasiticides
- Hospitals
- Clinics
- Pharmacies And Drug Stores
- Oral
- Livestock
- Companion Animals
- Inactivated Vaccines
- Attenuated Vaccines
- Recombinant Vaccines
Strategic Insights
Veterinary Pharmaceuticals Market Growth Drivers- Rising Animal Health Awareness: The growing awareness about animal health and the increasing concern among pet owners regarding their animals' well-being have significantly fueled the Veterinary Pharmaceuticals Market. As pet ownership continues to rise globally, owners are more informed and willing to invest in quality veterinary care, which directly drives demand for various veterinary pharmaceuticals. This trend is also observed in the livestock sector, where farmers are increasingly adopting advanced medications to ensure the health and productivity of their animals.
- Increasing Pet Ownership and Humanization of Pets: The trend of "pet humanization"—where pets are increasingly considered family members—has become a major driver for the Veterinary Pharmaceuticals Market. As people invest more in their pets' health, they are looking for medications and treatments that ensure longevity and quality of life for their animals. This shift in consumer behavior has spurred the demand for pharmaceutical solutions that cater to companion animals, boosting market growth.
- Advances in Veterinary Medicine: The rapid advancements in veterinary medicine, including the development of new drugs, vaccines, and diagnostics, are significantly contributing to the Veterinary Pharmaceuticals Market growth. Cutting-edge technologies, such as gene editing and biotechnology, have opened up new avenues for treating and preventing diseases in animals. These innovations not only improve treatment outcomes but also create new revenue opportunities for the market, driving expansion.
- Shift Toward Preventive and Wellness-Oriented Veterinary Pharmaceuticals: There is a growing shift from reactive to preventive healthcare in the Veterinary Pharmaceuticals Market. Pet owners and farmers are becoming increasingly proactive about preventing diseases rather than just treating them when they occur. This has led to a rise in demand for preventive medications, such as vaccines, parasitic treatments, and nutritional supplements, which help ensure long-term animal health. The emphasis on wellness and preventive care will drive new product developments in the market, focusing on long-term health benefits and disease prevention.
- Sustainability and Eco-Friendly Veterinary Pharmaceuticals: With growing environmental concerns, the demand for sustainable and eco-friendly veterinary pharmaceuticals is on the rise. Manufacturers are being pushed to develop products with minimal environmental impact, using biodegradable packaging, plant-based ingredients, and eco-conscious production processes. This trend is driven by both regulatory pressure and consumer preference for environmentally responsible products. Veterinary pharmaceutical companies are investing in greener alternatives, such as organic treatments, waste reduction, and sustainable sourcing, which is expected to become a significant trend in the coming years.
- Smart Wearables for Animal Health Monitoring: The rise of wearable technology in human healthcare is translating into the Veterinary Pharmaceuticals Market, with smart wearables being developed to monitor the health of animals. These devices can track vital signs such as heart rate, body temperature, and activity levels in real-time. Veterinary professionals and pet owners can use this data to identify health issues earlier and administer the right pharmaceutical treatments at the right time. This trend will likely lead to a surge in the demand for pharmaceutical products designed to complement smart monitoring systems, creating a more integrated approach to animal health management.
- Development of Antibiotic Alternatives: The growing concern over antimicrobial resistance (AMR) in both human and animal populations presents a critical opportunity for the Veterinary Pharmaceuticals Market. There is an increasing need for alternatives to traditional antibiotics, which are often overused and contribute to the development of resistance. Companies that focus on developing non-antibiotic treatments, such as probiotics, bacteriophage therapies, or immunotherapies, are poised to meet this demand. These alternatives not only address the resistance issue but also align with the rising trend of sustainable and responsible use of pharmaceuticals in animals.
- Veterinary Pharmaceuticals for Livestock Management and Food Safety: With the global population steadily increasing, there is a growing demand for animal protein to meet nutritional needs. This puts pressure on livestock producers to maintain healthy herds and flocks, driving the demand for veterinary pharmaceuticals in food-producing animals. There is a notable opportunity in developing and supplying pharmaceutical solutions that enhance livestock productivity, prevent diseases, and ensure food safety. This includes vaccines, antibiotics (with careful regulation), and growth-promoting agents. Companies that innovate in these areas can benefit from long-term contracts with commercial farmers and agribusinesses.
- Veterinary Pharmaceuticals for Exotic and Wild Animals:
The growing interest in exotic pets and wildlife conservation presents an untapped market for veterinary pharmaceuticals tailored specifically to these animals. Treatments for exotic pets, such as reptiles, birds, and small mammals, are in high demand, but there is a limited range of pharmaceuticals designed for these species. Likewise, conservation efforts and the need to protect endangered wildlife from diseases create an opportunity for specialized veterinary medications. Pharmaceutical companies can expand into this niche market by developing medications and vaccines that cater to the unique needs of exotic and wild animals.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Veterinary Pharmaceuticals Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Veterinary Pharmaceuticals Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Veterinary Pharmaceuticals Market is expected to register a CAGR of 9% from 2025-2031.
The major factors impacting the Veterinary Pharmaceuticals Market are: Rising Animal Health Awareness, Increasing Pet Ownership and Humanization of Pets and Advances in Veterinary Medicine
Key future trends in this market are - Shift Toward Preventive and Wellness-Oriented Veterinary Pharmaceuticals, Sustainability and Eco-Friendly Veterinary Pharmaceuticals and Smart Wearables for Animal Health Monitoring
Key companies of this market are: Aratana Therapeutics, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., Eli Lilly and Company, Merck & Co., Inc., Virbac, Zoetis Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Veterinary Pharmaceuticals Market - By Product
1.3.2 Veterinary Pharmaceuticals Market - By End User
1.3.3 Veterinary Pharmaceuticals Market - By Route of Administration
1.3.4 Veterinary Pharmaceuticals Market - By Type of Animals
1.3.5 Veterinary Pharmaceuticals Market - By Vaccines
1.3.6 Veterinary Pharmaceuticals Market - By Antibiotics
1.3.7 Veterinary Pharmaceuticals Market - By Region
1.3.7.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VETERINARY PHARMACEUTICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VETERINARY PHARMACEUTICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VETERINARY PHARMACEUTICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. VETERINARY PHARMACEUTICALS - GLOBAL MARKET OVERVIEW
6.2. VETERINARY PHARMACEUTICALS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. VACCINES
7.3.1. Overview
7.3.2. Vaccines Market Forecast and Analysis
7.4. ANTIBIOTICS
7.4.1. Overview
7.4.2. Antibiotics Market Forecast and Analysis
7.5. PARASITICIDES
7.5.1. Overview
7.5.2. Parasiticides Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. PHARMACIES AND DRUG STORES
8.5.1. Overview
8.5.2. Pharmacies And Drug Stores Market Forecast and Analysis
9. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. OTHERS
9.4.1. Overview
9.4.2. Others Market Forecast and Analysis
10. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF ANIMALS
10.1. OVERVIEW
10.2. TYPE OF ANIMALS MARKET FORECASTS AND ANALYSIS
10.3. LIVESTOCK
10.3.1. Overview
10.3.2. Livestock Market Forecast and Analysis
10.4. COMPANION ANIMALS
10.4.1. Overview
10.4.2. Companion Animals Market Forecast and Analysis
11. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - VACCINES
11.1. OVERVIEW
11.2. VACCINES MARKET FORECASTS AND ANALYSIS
11.3. INACTIVATED VACCINES
11.3.1. Overview
11.3.2. Inactivated Vaccines Market Forecast and Analysis
11.4. ATTENUATED VACCINES
11.4.1. Overview
11.4.2. Attenuated Vaccines Market Forecast and Analysis
11.5. RECOMBINANT VACCINES
11.5.1. Overview
11.5.2. Recombinant Vaccines Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis
12. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - ANTIBIOTICS
12.1. OVERVIEW
12.2. ANTIBIOTICS MARKET FORECASTS AND ANALYSIS
12.3. TETRACYCLINES
12.3.1. Overview
12.3.2. Tetracyclines Market Forecast and Analysis
12.4. PENICILLINS
12.4.1. Overview
12.4.2. Penicillins Market Forecast and Analysis
12.5. SULPHONAMIDES
12.5.1. Overview
12.5.2. Sulphonamides Market Forecast and Analysis
12.6. MACROLIDES
12.6.1. Overview
12.6.2. Macrolides Market Forecast and Analysis
12.7. AMINOGLYCOSIDES
12.7.1. Overview
12.7.2. Aminoglycosides Market Forecast and Analysis
12.8. OTHERS
12.8.1. Overview
12.8.2. Others Market Forecast and Analysis
13. VETERINARY PHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Veterinary Pharmaceuticals Market Overview
13.1.2 North America Veterinary Pharmaceuticals Market Forecasts and Analysis
13.1.3 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.1.4 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.1.5 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.1.6 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.1.7 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.1.8 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.1.9 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.1.9.1 United States Veterinary Pharmaceuticals Market
13.1.9.1.1 United States Veterinary Pharmaceuticals Market by Product
13.1.9.1.2 United States Veterinary Pharmaceuticals Market by End User
13.1.9.1.3 United States Veterinary Pharmaceuticals Market by Route of Administration
13.1.9.1.4 United States Veterinary Pharmaceuticals Market by Type of Animals
13.1.9.1.5 United States Veterinary Pharmaceuticals Market by Vaccines
13.1.9.1.6 United States Veterinary Pharmaceuticals Market by Antibiotics
13.1.9.2 Canada Veterinary Pharmaceuticals Market
13.1.9.2.1 Canada Veterinary Pharmaceuticals Market by Product
13.1.9.2.2 Canada Veterinary Pharmaceuticals Market by End User
13.1.9.2.3 Canada Veterinary Pharmaceuticals Market by Route of Administration
13.1.9.2.4 Canada Veterinary Pharmaceuticals Market by Type of Animals
13.1.9.2.5 Canada Veterinary Pharmaceuticals Market by Vaccines
13.1.9.2.6 Canada Veterinary Pharmaceuticals Market by Antibiotics
13.1.9.3 Mexico Veterinary Pharmaceuticals Market
13.1.9.3.1 Mexico Veterinary Pharmaceuticals Market by Product
13.1.9.3.2 Mexico Veterinary Pharmaceuticals Market by End User
13.1.9.3.3 Mexico Veterinary Pharmaceuticals Market by Route of Administration
13.1.9.3.4 Mexico Veterinary Pharmaceuticals Market by Type of Animals
13.1.9.3.5 Mexico Veterinary Pharmaceuticals Market by Vaccines
13.1.9.3.6 Mexico Veterinary Pharmaceuticals Market by Antibiotics
13.2. EUROPE
13.2.1 Europe Veterinary Pharmaceuticals Market Overview
13.2.2 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis
13.2.3 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.2.4 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.2.5 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.2.6 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.2.7 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.2.8 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.2.9 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Veterinary Pharmaceuticals Market
13.2.9.1.1 Germany Veterinary Pharmaceuticals Market by Product
13.2.9.1.2 Germany Veterinary Pharmaceuticals Market by End User
13.2.9.1.3 Germany Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.1.4 Germany Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.1.5 Germany Veterinary Pharmaceuticals Market by Vaccines
13.2.9.1.6 Germany Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.2 France Veterinary Pharmaceuticals Market
13.2.9.2.1 France Veterinary Pharmaceuticals Market by Product
13.2.9.2.2 France Veterinary Pharmaceuticals Market by End User
13.2.9.2.3 France Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.2.4 France Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.2.5 France Veterinary Pharmaceuticals Market by Vaccines
13.2.9.2.6 France Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.3 Italy Veterinary Pharmaceuticals Market
13.2.9.3.1 Italy Veterinary Pharmaceuticals Market by Product
13.2.9.3.2 Italy Veterinary Pharmaceuticals Market by End User
13.2.9.3.3 Italy Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.3.4 Italy Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.3.5 Italy Veterinary Pharmaceuticals Market by Vaccines
13.2.9.3.6 Italy Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.4 Spain Veterinary Pharmaceuticals Market
13.2.9.4.1 Spain Veterinary Pharmaceuticals Market by Product
13.2.9.4.2 Spain Veterinary Pharmaceuticals Market by End User
13.2.9.4.3 Spain Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.4.4 Spain Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.4.5 Spain Veterinary Pharmaceuticals Market by Vaccines
13.2.9.4.6 Spain Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.5 United Kingdom Veterinary Pharmaceuticals Market
13.2.9.5.1 United Kingdom Veterinary Pharmaceuticals Market by Product
13.2.9.5.2 United Kingdom Veterinary Pharmaceuticals Market by End User
13.2.9.5.3 United Kingdom Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.5.4 United Kingdom Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.5.5 United Kingdom Veterinary Pharmaceuticals Market by Vaccines
13.2.9.5.6 United Kingdom Veterinary Pharmaceuticals Market by Antibiotics
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Veterinary Pharmaceuticals Market Overview
13.3.2 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis
13.3.3 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.3.4 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.3.5 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.3.6 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.3.7 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.3.8 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.3.9 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Veterinary Pharmaceuticals Market
13.3.9.1.1 Australia Veterinary Pharmaceuticals Market by Product
13.3.9.1.2 Australia Veterinary Pharmaceuticals Market by End User
13.3.9.1.3 Australia Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.1.4 Australia Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.1.5 Australia Veterinary Pharmaceuticals Market by Vaccines
13.3.9.1.6 Australia Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.2 China Veterinary Pharmaceuticals Market
13.3.9.2.1 China Veterinary Pharmaceuticals Market by Product
13.3.9.2.2 China Veterinary Pharmaceuticals Market by End User
13.3.9.2.3 China Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.2.4 China Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.2.5 China Veterinary Pharmaceuticals Market by Vaccines
13.3.9.2.6 China Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.3 India Veterinary Pharmaceuticals Market
13.3.9.3.1 India Veterinary Pharmaceuticals Market by Product
13.3.9.3.2 India Veterinary Pharmaceuticals Market by End User
13.3.9.3.3 India Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.3.4 India Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.3.5 India Veterinary Pharmaceuticals Market by Vaccines
13.3.9.3.6 India Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.4 Japan Veterinary Pharmaceuticals Market
13.3.9.4.1 Japan Veterinary Pharmaceuticals Market by Product
13.3.9.4.2 Japan Veterinary Pharmaceuticals Market by End User
13.3.9.4.3 Japan Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.4.4 Japan Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.4.5 Japan Veterinary Pharmaceuticals Market by Vaccines
13.3.9.4.6 Japan Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.5 South Korea Veterinary Pharmaceuticals Market
13.3.9.5.1 South Korea Veterinary Pharmaceuticals Market by Product
13.3.9.5.2 South Korea Veterinary Pharmaceuticals Market by End User
13.3.9.5.3 South Korea Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.5.4 South Korea Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.5.5 South Korea Veterinary Pharmaceuticals Market by Vaccines
13.3.9.5.6 South Korea Veterinary Pharmaceuticals Market by Antibiotics
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Veterinary Pharmaceuticals Market Overview
13.4.2 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis
13.4.3 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.4.4 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.4.5 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.4.6 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.4.7 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.4.8 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.4.9 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Veterinary Pharmaceuticals Market
13.4.9.1.1 South Africa Veterinary Pharmaceuticals Market by Product
13.4.9.1.2 South Africa Veterinary Pharmaceuticals Market by End User
13.4.9.1.3 South Africa Veterinary Pharmaceuticals Market by Route of Administration
13.4.9.1.4 South Africa Veterinary Pharmaceuticals Market by Type of Animals
13.4.9.1.5 South Africa Veterinary Pharmaceuticals Market by Vaccines
13.4.9.1.6 South Africa Veterinary Pharmaceuticals Market by Antibiotics
13.4.9.2 Saudi Arabia Veterinary Pharmaceuticals Market
13.4.9.2.1 Saudi Arabia Veterinary Pharmaceuticals Market by Product
13.4.9.2.2 Saudi Arabia Veterinary Pharmaceuticals Market by End User
13.4.9.2.3 Saudi Arabia Veterinary Pharmaceuticals Market by Route of Administration
13.4.9.2.4 Saudi Arabia Veterinary Pharmaceuticals Market by Type of Animals
13.4.9.2.5 Saudi Arabia Veterinary Pharmaceuticals Market by Vaccines
13.4.9.2.6 Saudi Arabia Veterinary Pharmaceuticals Market by Antibiotics
13.4.9.3 U.A.E Veterinary Pharmaceuticals Market
13.4.9.3.1 U.A.E Veterinary Pharmaceuticals Market by Product
13.4.9.3.2 U.A.E Veterinary Pharmaceuticals Market by End User
13.4.9.3.3 U.A.E Veterinary Pharmaceuticals Market by Route of Administration
13.4.9.3.4 U.A.E Veterinary Pharmaceuticals Market by Type of Animals
13.4.9.3.5 U.A.E Veterinary Pharmaceuticals Market by Vaccines
13.4.9.3.6 U.A.E Veterinary Pharmaceuticals Market by Antibiotics
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Veterinary Pharmaceuticals Market Overview
13.5.2 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis
13.5.3 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.5.4 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.5.5 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.5.6 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.5.7 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.5.8 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.5.9 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Veterinary Pharmaceuticals Market
13.5.9.1.1 Brazil Veterinary Pharmaceuticals Market by Product
13.5.9.1.2 Brazil Veterinary Pharmaceuticals Market by End User
13.5.9.1.3 Brazil Veterinary Pharmaceuticals Market by Route of Administration
13.5.9.1.4 Brazil Veterinary Pharmaceuticals Market by Type of Animals
13.5.9.1.5 Brazil Veterinary Pharmaceuticals Market by Vaccines
13.5.9.1.6 Brazil Veterinary Pharmaceuticals Market by Antibiotics
13.5.9.2 Argentina Veterinary Pharmaceuticals Market
13.5.9.2.1 Argentina Veterinary Pharmaceuticals Market by Product
13.5.9.2.2 Argentina Veterinary Pharmaceuticals Market by End User
13.5.9.2.3 Argentina Veterinary Pharmaceuticals Market by Route of Administration
13.5.9.2.4 Argentina Veterinary Pharmaceuticals Market by Type of Animals
13.5.9.2.5 Argentina Veterinary Pharmaceuticals Market by Vaccines
13.5.9.2.6 Argentina Veterinary Pharmaceuticals Market by Antibiotics
14. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VETERINARY PHARMACEUTICALS MARKET
14.1 North America
14.2 Europe
14.3 Asia-Pacific
14.4 Rest of the World
15. INDUSTRY LANDSCAPE
15.1. MERGERS AND ACQUISITIONS
15.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
15.3. NEW PRODUCT LAUNCHES
15.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
16. VETERINARY PHARMACEUTICALS MARKET, KEY COMPANY PROFILES
16.1. ARATANA THERAPEUTICS, INC.
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Products and Services
16.1.4. Financial Overview
16.1.5. SWOT Analysis
16.1.6. Key Developments
16.2. BAYER AG
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Products and Services
16.2.4. Financial Overview
16.2.5. SWOT Analysis
16.2.6. Key Developments
16.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Products and Services
16.3.4. Financial Overview
16.3.5. SWOT Analysis
16.3.6. Key Developments
16.4. CEVA SANTE ANIMALE
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Products and Services
16.4.4. Financial Overview
16.4.5. SWOT Analysis
1. Aratana Therapeutics, Inc.
2. Bayer AG
3. Boehringer Ingelheim International GmbH
4. Ceva Sante Animale
5. Dechra Pharmaceuticals PLC
6. Elanco Animal Health Inc.
7. Eli Lilly and Company
8. Merck & Co., Inc.
9. Virbac
10. Zoetis Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For